Xianling Guo
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Physiology top 5%
Papers in
-
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 4
- Oncology 19
- Cancer Immunotherapy and Biomarkers 5
- Cancer-related Molecular Pathways 4
- Co-authors
- Lixin Wei (19 shared papers)Kai Sun (7 shared papers)Mengchao Wu (10 shared papers)Jianrui Song (6 shared papers)Qiudong Zhao (6 shared papers)Shanshan Zhang (7 shared papers)Qing Xu (20 shared papers)Wei-jie Deng (4 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Cancer Letters (5 papers)Cancer Biology & Therapy (2 papers)BMC Cancer (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xianling Guo
47 papers receiving 1.6k citations
Xianling Guo's Hit Papers
Peers
Comparison fields: 5 of 96
- Cancer Research 369
- Physiology 83
- Oncology 492
- Epidemiology 609
- Molecular Biology 950
Countries citing papers authored by Xianling Guo
This map shows the geographic impact of Xianling Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianling Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianling Guo more than expected).
Fields of papers citing papers by Xianling Guo
This network shows the impact of papers produced by Xianling Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianling Guo. The network helps show where Xianling Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Xianling Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer Hit paper breakdown → | 2021 | 195 |
| 2 | 2009 | 159 | |
| 3 | 2012 | 158 | |
| 4 | 2013 | 135 | |
| 5 | 2008 | 116 | |
| 6 | 2012 | 93 | |
| 7 | 2009 | 69 | |
| 8 | 2021 | 60 | |
| 9 | 2017 | 55 | |
| 10 | 2008 | 52 | |
| 11 | 2011 | 47 | |
| 12 | 2019 | 44 | |
| 13 | 2021 | 41 | |
| 14 | 2020 | 36 | |
| 15 | 2014 | 34 | |
| 16 | 2014 | 32 | |
| 17 | 2008 | 32 | |
| 18 | 2009 | 30 | |
| 19 | 2021 | 29 | |
| 20 | 2008 | 25 |
About Xianling Guo
Xianling Guo is a scholar working on Molecular Biology, Oncology, Epidemiology, Immunology and Surgery, having authored 47 papers that have together received 1.7k indexed citations. Recurring topics across this work include Autophagy in Disease and Therapy (11 papers), Epigenetics and DNA Methylation (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Cancer Research and Treatments (4 papers), Telomeres, Telomerase, and Senescence (4 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (369 citations), Physiology (83 citations), Oncology (492 citations), Epidemiology (609 citations) and Molecular Biology (950 citations). Xianling Guo has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Lixin Wei, Kai Sun, Mengchao Wu, Jianrui Song, Qiudong Zhao, Shanshan Zhang, Qing Xu, Wei-jie Deng, Fei Hu and Juemin Fang. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters, Cancer Biology & Therapy, BMC Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.